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Abstract 
Background. The purpose of this study was to explore qualitative comments about massage 
therapy (MT) from breast cancer survivors. Patients suffering from cancer commonly use 
complementary alternative therapies for treatment and recovery, including massage therapy.  
Quantitative studies have shown that MT may reduce distress and enhance symptom control in 
cancer patients.  
Methods. Four focus groups were conducted. Specific queries were identified for the group 
discussions to include: (1) prior massage experiences, (2) research study enrollment process, (3) 
MT intervention, and (4) the impact of MT.  Participants also completed a 14-question survey, 
answering with forced-choice responses and ranking responses utilizing a four point Likert scale.  
Results. Themes emerged from the analysis including physical and mental benefits of MT, 
control of decision-making during treatment, and positive implications of non-invasive 
treatment. 
Conclusions.  Efforts should be directed toward treatment that allows patients a sense of 
“control” and “empowerment.”  KJM 2009; 3(1):2-12. 
 
 
Introduction 
Breast cancer is a major public health 
issue with an estimated 212,920 new cases 
and 40,970 deaths in the US for 2006.1 Of 
new cancer diagnoses among women, one-
third are breast cancer with 80% of breast 
cancer patients having a 5-year minimum 
survival prognosis and localized breast 
cancer patients having a 98% survival rate 
for a minimum of 5 years.2 
Several studies reported using massage 
in addition to other medical treatments for 
breast cancer patients (see Table 1).  Study 
population prevalence of women 
participating in massage therapy ranged 
from 5.2% to 28% with an all-cancer 
survivor population-based prevalence of 
11.2%.3 There is a positive correlation 
between survival of breast cancer and the 
completion of the full treatment regimen of 
chemotherapy.4,5   Therefore,   alternative  or  
 
complementary therapies that ameliorate  
the side effects of cancer treatment protocols 
should be investigated.  
The American Cancer Society (ACS) 
strives to gain a better understanding of the 
causes underlying behavioral change of 
treatment protocols for breast cancer 
patients.1 Using massage therapy (MT) to 
improve the psychological outlook of breast 
cancer patients may boost immune response, 
thereby ameliorating their perceptions of 
side effects caused by treatment and 
improving nausea6-8, pain7-10, sleep11, 
anxiety9,10,12, and aspects of quality of 
life10,13,14.  In a 2002 study, women with 
breast cancer who received three 45-minute 
massages per week for five weeks had 
improved moods with decreased stress, 
anxiety, and anger after the first and last 
massage.11 Additionally, cancer patients 
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who received massage with aromatherapy 
reported a statistically significant reduction 
in stress and a statistically significant 
improvement in cancer-related symptoms 
and quality of life.11,15 
Focus groups and surveys used to assess 
breast cancer issues and treatment needs 
have previously included quality of life16, 
barriers to exercise17, cancer survivor-
ship18,19, coping skills20-22, and satisfaction 
of care23.  A recent analysis found gaps in 
several key research categories including 
pathophysiology, detection, treatment, pre-
vention, and psychosocial aspects of breast 
cancer.24 However, focus group research 
studies involving complementary and 
alternative medicine (CAM) are few.25-29   
The present study utilized a series of 
focus groups with breast cancer patients to 
gather information about patient experiences 
with massage therapy (MT).  Interview 
questions were constructed through the 
theoretical underpinnings of information 
seeking 30-33 and decision-making 26, 34-37 for 
patients undergoing breast cancer treatment.
 
Table 1.  Pattern of massage therapy use in research with breast cancer patients. 
 
Author/Year/Country Type of CAM Prevalence 
Crocetti et al., 1998, Italy38 Manual healing (massage) 16% 
Burstein et al., 1999, USA39 Massage 5.2% 
Vandecreek et al., 1999, 
USA40 
Massage 10% 
Boon et al., 2000, Canada41 Body work used at least once 
(reiki, massage, therapeutic 
touch) 
14.1% 
Gotay and Dumitriu, 2000, 
USA42
 
Massage 20.8% 
Lee et al., 2000, USA43 Physical healing methods 
(including massage) 
14.2% overall 
(7% blacks, 12% Chinese, 
17% Latino, 21% white) 
Rees et al., 2000, UK44 Massage 13.9% 
Alferi et al., 2001, USA45 Massage/body work 11% 
Lengacher et al., 2002, USA46 Massage used at least once 27% 
Shen et al., 2002, USA47 Massage 28% 
Nagel et al., 2004, Germany48 Massage included as  
“Other CAM types” 6% 
Buettner et al., 2006, USA49 Massage used for any reason 
(i.e., wellness, bodily pain) 23% 
Helyer et al., 2006, Canada50 Massage  26% 
Lengacher et al., 2006, USA51 Massage (a traditional and 
ethnic medicine category) 25% 
Molassiotis et al., 2006, 
European countries52 
Massage 12.7% pre-cancer 
15% since diagnosis 
Boon et al., 2007, Canada53 Massage 9.8%  
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Methods 
Massage therapy pilot program. Fifty-
one women who were undergoing breast 
cancer treatment, lived within a 100-mile 
radius of a regional cancer center, and had a 
physician referral for participation, were 
recruited for an MT pilot program. The MT 
process was explained to the patient and 
usual MT protocols were followed.54 The 
patients indicated their willingness to 
participate in research and were selected as a 
convenience sample. Patients were excluded 
if they had contraindications to massage 
therapy, including: active skin rash, open 
cutaneous lesions, current diagnosis of 
venous thrombosis or symptomatic 
varicosity, untreated anemia (hemoglobin 
level less than 8 mg/dl), or current touch 
therapy. The pilot study was conducted for 
five weeks in 2006.  The focus groups were 
held March-April 2007.  
Focus group study.  All surviving patient 
participants utilizing MT as a part of 
treatment were invited to attend the focus 
group discussions. Four focus groups were 
conducted with 21 volunteering participants 
in an urban Kansas county.   
The study design emphasized the 
contribution from respondents to assess 
utilizing MT as a type of CAM and as a part 
of the treatment regimen for breast cancer 
patients at a regional medical cancer center. 
This research study was designed to better 
understand and assess changes in 
perceptions and beliefs of participants 
toward MT, and the impact the therapy may 
have had on side effects of breast cancer 
treatment, functional status, and quality of 
life. Researchers identified specific queries 
not examined previously in qualitative 
studies about MT, including (1) prior 
massage experiences, (2) research study 
enrollment process, (3) MT intervention, 
and (4) the impact of MT. 
Study approval was granted by a 
university institutional review board.    Each 
 
participant gave written informed consent 
prior to beginning the focus group protocol.  
The four sessions each lasted approximately 
90 minutes.  The sessions were held at the 
same location and audio-recorded.  
Participant survey.  Subjects completed a 
14-question survey, answering with forced-
choice responses, and ranking responses 
utilizing a 4-point Likert scale. The survey 
collected quantitative data to corroborate the 
verbal comments and ensure convergent 
validation. Questions included a brief 
description of cancer diagnosis, date of 
original diagnosis, identification of other 
CAM therapies used, rating of the overall 
MT experience, possibility of 
recommending MT to other cancer patients, 
and demographic information.  
All groups were moderated by the same 
professional female facilitator, who had 19 
years of experience in qualitative research 
for health communication.  The facilitator 
used a standard script for each meeting. She 
introduced two terms at the beginning of 
each session to create a common definition 
throughout the discussion. The facilitator 
defined complementary alternatives as, 
“Encompasses both the use of natural 
healthcare products (including herbs, 
homeopathy, and nutritional supplements) 
and the process of seeking health advice 
from individuals who are not generally 
considered conventional health care 
professionals (i.e., herbalists, homeopaths, 
naturopathic practitioners, and acupunc-
turists).” Quality of life was defined as, 
“The overall enjoyment of life.” As terms 
were introduced, the facilitator asked 
participants if they understood the terms and 
concepts.  Definitions were given when 
participants requested clarification. 
Faculty members from the Department 
of Preventive Medicine and Public Health at 
the University of Kansas School of 
Medicine-Wichita    conducted    interviews, 
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transcribed comments, and subsequently 
analyzed the data.  In addition to the 
moderator, another researcher was present 
during focus group sessions to take notes.   
Immediately after each focus group 
session ended, the moderators convened to 
review the findings and assure that all key 
points were captured in writing.  Then, they 
listened to the audiotape of each session, 
read transcripts, identified conclusions, and 
grouped the findings into categories for 
analysis.  A summary was compiled for each 
focus group.  
Data analysis.  Questionnaire data from 
participant surveys were analyzed using 
SPSS 14.0 software (SPSS, Inc., Chicago, 
IL). The digital recordings were transcribed 
to text and uploaded to Ethnograph 5.0 
(Qualis Research, Colorado Springs, CO), a 
professional qualitative software program 
for data-making. Unitizing the data occurred 
on a series of levels: by physical group 
(focus group session), by content (discussion 
question asked), by respondent, and by 
context (stated positively or negatively). The 
moderators cut full quotes that concisely 
summarized thoughts from the transcript and 
used them to describe themes.   
After all transcripts were unitized, they 
were compared for themes within discussion 
questions and across groups.  Similarity of 
consensus norms across sites implied 
validity of findings.  A final analysis 
assessing convergence and divergence of 
themes across the groups was assembled.  
Similarities and differences between special 
populations were described based on 
differences between focus group consensus 
findings and discussion results when 
stratified by groups.  Triangulation of 
qualitative and quantitative responses were 
categorized and compared to strengthen 
validity and reliability of the study. 
 
 
 
Results 
Results stemmed from comments made 
during the focus group sessions and 
responses from the survey demographic 
questions. All focus group sessions were 
held after the completion of the MT 
intervention. All of the participants who 
completed the intervention and chose to be a 
part of the focus group study were included.  
Participant demographics.  Twenty-one 
female subjects participated in the focus 
groups.  The majority classified themselves 
as Caucasian (86%), married (62%), 
between 50-59 years old (48%), college 
educated (48%), from an urban area (38%), 
and earning an annual income between 
$20,000 and $40,000 (33%; Table 2). The 
participants shared similar demographics to 
the deceased participants from the Massage 
Therapy Pilot Program.   
The majority (91%) of participants 
reported using CAM with traditional cancer 
treatments.  Some women (10%) reported 
using up to six different types of CAM.  The 
most common types (excluding MT) were 
spiritual and religious practices (71%) and 
vitamins (57%; Table 3). The participants 
listed their cancer diagnoses as infiltrating 
ductal carcinoma (52.4%), metastasic breast 
cancer (23.8%), lobular carcinoma (5%), or 
inflammatory breast cancer (5%). Several 
participants (14.3%) indicated they were 
diagnosed with more than one type of breast 
cancer. Time since diagnosis ranged from 6 
months to 8 years (mean = 2.8 years). 
Previous massage experience. The 
facilitator began each focus group by asking 
about previous experience with massage. A 
majority (61.9%) of participants responded 
that they had received some type of massage 
prior to this research program, usually one 
or two MT sessions  received 3 to 25 years  
prior  to  this study.  When  asked  about  the  
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type of massage they had received, the 
techniques were distinguished by using the 
terminology “regular,” “light,” and “hard” 
massages.  Some participants expressed pain 
associated with prior massages; as one 
participant said, “Of course it felt good at 
the time but the very next day, boy I was 
really in a different kind of pain.”   
 
Table 2. Demographics of focus group 
participants (n=20). 
Characteristic % 
Gender (Female) 100 
Race  
   Caucasian 85.7 
   Hispanic 4.8 
   Other 4.8 
   More than one race 4.8 
Marital Status  
   Married 61.9 
   Divorced 14.3 
   Single 14.3 
   Separated 4.8 
   Widowed 4.8 
Age  
   < 40 years of age 4.8 
   40-49 years 28.6 
   50-59 years 47.6 
   > 60 years 19.0 
Education Level  
   Some College 47.6 
   Graduated College 38.1 
   Graduate School 14.3 
Area of Residence  
   Urban 38.1 
   Suburban 28.6 
   Small town 23.8 
   Rural 9.5 
Annual Income  
   < $20,000 4.8 
   $20,000 - $40,000 33.3 
   $40,000 - $60,000 23.8 
   $60,000 - $80,000 19.0 
   > $80,000 
   No response 
9.5 
9.6 
Table 3. Complementary alternatives 
utilized in addition to MT. 
Types           % 
Spiritual / Religious      71.4 
Vitamins      57.1 
Supplements      33.3 
Herbs      14.3 
Meditation      14.3 
Exercise      14.3 
Yoga/ Pilates       4.8 
Visualization       4.8 
Chiropractic manipulation        4.8 
Special diets       4.8 
Note: No participants indicated using 
homeopathic medicine, traditional Chinese 
medicine, Reiki therapy, or acupuncture. 
 
When asked their opinion of MT prior to 
participation in this program, participants 
expressed a variety of perceptions. Two 
overarching previous opinions were based 
on (1) the positive effects of massage, 
including feeling pampered and being 
relaxed and (2) negative preconceived ideas 
that massage was “for the wealthy,” “wasn’t 
for me,” and “wasn’t used for anything 
medically”. Although some of the 
participants previously had encountered 
negative or painful massages or had negative 
preconceived ideas related to massage, all 
were willing to try massage for this study.  
MT enrollment process. The participants 
reported learning about the MT study mainly 
through word-of-mouth from clinic nurses, 
staff, and other study patients. The 
enrollment process was described as being 
“simple,” not requiring extensive 
permissions or paperwork. Choosing to 
participate in the focus group usually was 
based on previous knowledge or perceptions 
of massage benefits, while others joined 
because the program was free and they 
qualified, as well as, they would do 
“anything to help” and participation 
“couldn’t hurt”.  One woman described her 
decision as being based on feeling more 
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normal because the massages are 
“something open to everybody, anybody can 
go in and get a massage.” Another survivor 
reported that she chose to participate in the 
pilot MT study because of the “powerful 
incentive to know that I could be a part of 
something on a global scale every woman or 
male…could benefit from.” 
Comments from participants indicated 
that nurses were more likely than physicians 
to discuss MT or other CAM therapies due 
to the nurses’ frequent interaction with the 
cancer patients. Participants’ descriptions of 
discussions with physicians about CAM and 
MT were mixed: “[I] made a point of telling 
him,” and “he said anything that makes you 
feel good, I am for it”. Some participants 
were unable or unwilling to discuss their 
involvement in the MT study with their 
physicians because of a lack of personal 
rapport and conflicting information about 
CAM options. One woman described her 
hesitation as being related to “this is 
unfamiliar ground, you don’t really know 
what to say, and I don’t want to bother 
people [with questions].”  
Experience with the MT intervention.  
All focus group participants (100%) rated 
their experience with MT as “very good” on 
a 4-point Likert scale. When asked to rate if 
they would recommend MT to other women 
undergoing breast cancer, all of the 
participants indicated they would 
recommend or highly recommend MT. 
Participants in every group described a 
continued interest in learning more about 
MT and the results of current research.  
Participants across the focus groups 
called for therapy sessions to be longer in 
length and more frequent. One participant 
said the half-hour sessions were not 
“adequate time to really appreciate the 
massage and what it did for you and how it 
made you feel. It worked, but an hour, I 
think, is more beneficial.” All the women 
(100%) agreed that the sessions should be 
one hour in length, but did not agree on the 
number and frequency of the sessions. When 
asked, “How often the participants would 
want to do MT in the future?”, 95% 
responded that they would want to continue 
with MT at a frequency of daily (14.3%), 
weekly (42.9%), monthly (33.3%), and 
every six months (4.8%). One focus group 
participant (4.8%) indicated that she would 
not want to participate in MT again; the 
participant gave no clarification or further 
explanation. 
Focus group themes. When further 
probed about the MT intervention, four 
major themes emerged across the four 
sessions. Participants commonly described: 
(1) the perceived physiological and (2) 
psychological benefits, (3) the ability to be 
“in control” of part of their treatment, and 
(4) the nonclinical feel of MT.  
Physiological benefits. Throughout the 
focus groups, the medical benefits of MT 
were discussed extensively by the 
participants. Responses centered on the 
relaxation of the body that resulted in the 
following benefits: reduced tension in 
muscles, relieved pain, increased strength 
and energy, and improved sleeping patterns. 
The majority of participants (66.7%) 
credited MT with easing the side effects of 
their treatment. In general, the opinions of 
the therapy were directed at a positive 
healing process with one respondent stating 
that her “body works better” after MT. 
Psychological benefits. The majority of 
participants discussed how MT benefited 
them psychologically by reducing stress, 
clearing their minds, and generating a 
positive feeling of self and circumstances. 
One participant stated that MT helped her to 
persevere through her traditional medical 
treatments because the therapy allowed the 
“worry to go out of [her] mind” and another 
commented that the clinic “is not a place I 
really want to go again, but I do because the 
massages are more important than the reason 
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I was here”.  Many participants spoke about 
how MT made them feel respected as a 
person, with 52.4% reporting the therapeutic 
touch helped them to reconnect with 
themselves and 71.4% felt support during 
the therapy.  One woman discussed why she 
recommends MT to others:  
“It does make a difference in your 
mentality, how you perceive you are 
still a person, it hasn’t taken over 
everything in your body… you aren’t 
just a statistic, you aren’t just another 
medical patient, you are actually still 
a person and you have feelings. And 
it makes you relax and accept the 
fight that you have to give.” 
Empowerment. Another benefit of study 
participation was that the participants were 
able to “own” their decision to participate. 
Unlike many other decisions that doctors 
and specialists recommend after a cancer 
diagnosis (e.g., radiation, chemotherapy, and 
medication), MT often was reported as 
“something I could choose to do” and the 
information learned during the sessions was 
“something you can manage within your 
own control”. One participant described her 
decision as one that “allowed me to do 
something for myself that I felt good about 
without someone invading my body with 
stuff I wasn’t sure about. It’s real 
positive…I felt it was caring for myself in a 
different way.” Empowerment gave many of 
the women a positive event to look forward 
to and commonly was described as the 
catalyst for helping a survivor follow 
through on the difficult traditional medical 
treatments, as one woman said “it made me 
feel more determined to fight it”. 
Nonclinical therapy. Due to the invasive 
nature of treating breast cancer with 
radiation and chemotherapy, the women 
mentioned how quickly a breast cancer 
patient must lose her modesty. The overall 
consensus was that with MT, women were 
not treated as just another patient, but were 
“dignified” and “respected”.  One woman 
remembered a chemotherapy visit as: 
“They put me in there with a man… 
this is a man that doesn’t know me, 
and here I am… I don’t have a breast 
anymore, but what I have I would 
like to keep it not exposed… it is 
kind of undignified…you are all laid 
up there, they come have a peek… it 
was not dignified.” 
MT was classified by many as 
nonclinical; participants described the touch 
as concentrating more holistically on the 
person and not invasively on the disease. 
Common responses about the kind of touch 
during MT were, “it wasn’t medical, they 
weren’t doing a procedure to you or sticking 
you or cutting you or hooking you up, so it 
was different” and “[MT] is a healthy touch, 
it is a healing touch”.  
Impact of MT. Participants described 
MT as a way to help them complete the 
cancer treatment, indicating it was an 
important component of their treatment 
regimen with terms like “one big package,” 
and “just one of the therapies available.” 
Respondents described their continuation of 
MT as a part of their personal treatment 
program and several of them recalled 
experiencing “trauma” at the end of the MT 
study. One participant said she continued 
MT after the study ended “to get through the 
breaking away from the treatment…eased 
me out of it”, while others expressed a need 
to continue because “it still hurts” and 
because “chemotherapy has continued”.  
Most participants indicated a desire to 
continue with MT after their breast cancer 
treatment, but some reported that they 
lacked the financial resources to continue 
paying for additional sessions. When asked 
if insurance should cover MT for cancer 
patients, all participants responded, “Yes!” 
Participants were adamant in the responses 
such as, “they give you all kind of drugs for 
everything…and there has got to be a limit” 
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and others indicated a strong desire to lobby 
insurance companies. 
 
Discussion 
There were several limitations to this 
study as well as areas of opportunity for 
future research.  Although funding was 
extended to the assessment of MT as a CAM 
treatment option, it would have been 
valuable to have a larger number of 
participants in the pilot study and the focus 
groups. Also, while the participant 
characteristics in the study population were 
variable, the demographics may not 
generalize. Future studies should focus on 
recruiting more minority participants to 
ensure the cultural competency of responses 
for breast cancer patients.  Additionally, 
future studies could include an assessment 
of provider perceptions of MT as a variable 
for patient acceptance. Another area for 
future research is a similar study that utilizes 
a control group not participating in CAM or 
MT to confirm the reliability and validity of 
the responses.  Future studies also should 
investigate patient issues surrounding 
personal control, empowerment, and trust 
with the therapist. 
A qualitative method was chosen to 
extend the understanding of MT for breast 
cancer survivors through a deep, rich textual 
description of participant comments. All 
focus groups expressed consensus on topics 
such as physical benefits, reduced stress and 
anxiety, personal control over their choice to 
participate, and renewed sense of respect 
and dignity. A particularly valuable finding 
was the clear indication of a need for 
treatment that allows the patient a sense of 
“control” and “empowerment”.  
 
Implications 
These focus groups served as a 
preliminary indicator for the affects of MT 
on breast cancer patients.  While many gaps 
were identified, an important potential 
avenue for intervention was indicated.  
Participants placed trust in the massage 
therapist who provided massages for this 
program.  By identifying trusted, qualified 
massage therapists within a local or state-
level community, health care providers can 
ensure that these therapists are a part of the 
cancer treatment plan. 
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